Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (9.7), the stock would be worth ₩9 384.93 (2% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 9.9 | ₩9 600 |
0%
|
| 3-Year Average | 9.7 | ₩9 384.93 |
-2%
|
| 5-Year Average | 10.5 | ₩10 115.13 |
+5%
|
| Industry Average | 14 | ₩13 570.63 |
+41%
|
| Country Average | 9 | ₩8 680.49 |
-10%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
161.2B KRW | 9.9 | 14.2 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 38.9 | 39.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
59.4B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.9B CHF | 16.1 | 37.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
93.1B DKK | 13.4 | 23.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.2B USD | 22.2 | 32.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 12.1 | 32.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 19.8 | -15.6 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.8B CNY | 22.4 | 22.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
879B JPY | 21.7 | 49.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.3B CNY | 25.5 | 22.6 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 4.2 |
| Median | 9 |
| 70th Percentile | 16.6 |
| Max | 2 215 132.4 |
Other Multiples
Optus Pharmaceutical Co Ltd
Glance View
OPTUS Pharmaceutical Co., Ltd. engages in the manufacture and sale of ophthalmic products. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 171 full-time employees. The company went IPO on 2010-12-03. The firm is primarily engaged in the manufacture and sale of eye drops and ophthalmic preparations such as dry eye treatment agents, conjunctivitis treatment agents, anti-inflammatory medication agents, glaucoma treatment agents and others.
